Drugmakers Agree to $300M Settlement in MDL Over Hypertension Medication Benicar
Drugmakers Daiichi Sankyo and Forest Laboratories have agreed to a $300 million settlement in multidistrict litigation by users of hypertension drug Benicar who claimed they developed severe gastrointestinal side effects.
Attorneys placed the settlement on the record before U.S. District Judge Robert Kugler in Camden on Tuesday. The agreement would apply to about 2,000 cases from across the nation that were consolidated before Kugler, as well as another 100 cases pending in state Superior Court in Atlantic County. Kugler appointed former state Superior Court Judge Marina Corodemus, who served as a state mass tort judge, to oversee compliance with the agreement and dismissal of claims that fail to meet its conditions.